Frank Hübler

C.H. Boehringer Sohn AG & Co. KG operates as a holding company, with interests in the manufacturing of pharmaceutical products. It offers prescription drugs for the treatment of human respiratory, cardiovascular, gastrointestinal, and central nervous system diseases, including human immunodeficiency virus infection and cancer. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany.

BIOTHERAX biochemisch-pharmazeutische GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Michael Schmelmer, Martin Beck.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Finanzierungs GmbH is a financial services provider. The company is based in Ingelheim am Rhein, Germany. The CEOs are Jochen Gann, Martin Schwarz. The German company was founded in 1968.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Deutschland GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Martin Beck and Sabine Nikolaus.

Part of C.H. Boehringer Sohn AG & Co. KG, Boehringer Ingelheim Healthcare Innovation GmbH is an investment holding German company. The company is based in Ingelheim am Rhein, Germany. The CEOs of the company are Martin Black, Christiane Wijsen.

Boehringer Ingelheim Auslandsbeteiligungs GmbH operates an investment holding company, which through its subsidiaries engages in research, development, manufacture, and sale of pharmaceutical products and animal health care services. The company is headquartered in Ingelheim, Ingelheim.